Litigation
Untitled case
reversed/vacated in part24-2274
Auto-generating section 1 of 4: Case overview & background…
Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.
- Terminated
- 2025-05-06
Patents at issue (2)
Summary
Appeal arising from the February 2024 patent trial/injunction phase after the March 4, 2024 verdict. The Federal Circuit issued an opinion on May 6, 2025 reversing/vacating portions of the district court's injunction relating to open-label extensions, new clinical trials, and seeking FDA approval for additional indications. The narrative could not confirm whether any ruling on the '488 patent itself was appealed.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).